Squadron Capital Management LLC

CIK

2050709

Location

WESTMONT, IL

Portfolio Value

Small $272,919,020

Diversification

Diversified

Filing Date

Global Rank

#3,576 / 8,605 ▲ 444 · as of Mar 2026

Top Industry

Biotechnology 97.1%

3Y Alpha vs SPY

+89.7%

Period ended 3 months ago

Filed May 15, 2026 · 55d

2 quarters · since Dec 2025

Clone Performance

Feb 2026–Jul 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio

+21.1%

SPY

+10.0%

Annualised alpha

+34.9%

Max drawdown

−19.1%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

33 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025

Top Position

21.6%

+7.7 pts

Top 5

52.9%

+5.0 pts

Top 10

69.9%

+3.2 pts

HHI

851

Diversified+208

Portfolio Trend

2 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$272,919,020	33

Last Quarter's Activity

Export CSV

Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased

8 positions

Ticker	Company	Δ Shares	Shares	Value
RLMD	Relmada Therapeutics, Inc.	+1,774,571	8,474,571	$58,983,014
KALV	KalVista Pharmaceuticals, Inc.	+600,100	1,300,100	$26,171,013
IVA	Inventiva S.A.	+235,000	535,000	$2,969,250
EPRX	Eupraxia Pharmaceuticals Inc.	+180,000	680,000	$4,923,200
KOD	Kodiak Sciences Inc.	+88,290	380,000	$14,485,600
NXTC	NextCure, Inc.	+28,034	265,000	$2,830,200
GHRS	GH Research PLC	+10,000	325,000	$4,569,500
COGT	Cogent Biosciences, Inc.	+7,492	787,492	$30,310,567
No positions match the current search.

Trimmed

Positions the filer reduced

8 positions

Ticker	Company	Δ Shares	Shares	Value
PALI	Palisade Bio, Inc.	−1,500,000	3,000,000	$5,250,000
IKT	Inhibikase Therapeutics, Inc.	−725,000	3,500,000	$5,880,000
MAZE	Maze Therapeutics, Inc.	−232,500	257,500	$7,686,375
AVBP	ArriVent BioPharma, Inc.	−228,000	110,000	$2,537,700
TRAW	Traws Pharma, Inc.	−201,826	511,714	$936,436
LPCN	Lipocine Inc.	−80,000	450,000	$3,595,500
SPRB	Spruce Biosciences, Inc.	−57,800	12,200	$797,270
ABVX	Abivax S.A.	−15,000	130,000	$14,475,500
No positions match the current search.

New Positions

Positions the filer opened this quarter

15 positions

Ticker	Company	Shares	Value
ZNTL	Zentalis Pharmaceuticals, Inc.	4,031,000	$9,432,540
NKTR	Nektar Therapeutics	125,000	$8,993,750
ANL	Adlai Nortye Ltd.	1,265,231	$8,755,398
RLAY	Relay Therapeutics, Inc.	822,500	$8,183,875
IDYA	IDEAYA Biosciences, Inc.	224,300	$7,473,676
SCYX	Scynexis Inc	7,608,695	$6,977,173
CCCC	C4 Therapeutics, Inc.	2,250,000	$5,917,500
KPTI	Karyopharm Therapeutics Inc.	750,000	$4,177,500
PMN	ProMIS Neurosciences Inc.	324,977	$4,127,207
ALXO	Alx Oncology Holdings Inc	1,460,000	$2,927,300
CNTX	Context Therapeutics Inc.	1,100,000	$2,882,000
SLGL	Sol-Gel Technologies Ltd.	31,000	$2,455,820
TXMD	TherapeuticsMD, Inc.	420,421	$849,250
HOWL	Werewolf Therapeutics, Inc.	563,535	$469,424
NEUP	Neuphoria Therapeutics Inc.	76,728	$312,282
No positions match the current search.

Sold Out

Positions the filer fully exited

14 positions

Ticker	Company	Shares	Value
TERN	Terns Pharmaceuticals, Inc.	190,000	$7,676,000
TARS	Tarsus Pharmaceuticals, Inc.	80,000	$6,550,400
UPB	Upstream Bio, Inc.	230,650	$6,262,147
XENE	Xenon Pharmaceuticals Inc.	105,551	$4,730,795
DBVT	DBV Technologies S.A.	240,000	$4,600,800
HELP	Cybin Inc.	525,000	$4,294,500
BLTE	Belite Bio, Inc	26,000	$4,158,960
VERA	Vera Therapeutics, Inc.	60,000	$3,038,400
WVE	Wave Life Sciences Ltd.	175,000	$2,975,000
CMPS	COMPASS Pathways plc	388,287	$2,679,180
AVTX	Avalo Therapeutics, Inc.	130,000	$2,360,800
ZBIO	Zenas BioPharma, Inc.	36,000	$1,307,160
NTLA	Intellia Therapeutics, Inc.	81,000	$728,190
CLYM	Climb Bio, Inc.	100,000	$400,000
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

33 positions · $272,919,020 total · as of Mar 31, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
RLMD	Relmada Therapeutics, Inc. Healthcare	Added	8,474,571	+1,774,571	$58,983,014	+82.3%	21.61%
COGT	Cogent Biosciences, Inc. Healthcare	Added	787,492	+7,492	$30,310,567	+9.4%	11.11%
KALV	KalVista Pharmaceuticals, Inc. Healthcare	Added	1,300,100	+600,100	$26,171,013	+131.5%	9.59%
KOD	Kodiak Sciences Inc. Healthcare	Added	380,000	+88,290	$14,485,600	+77.6%	5.31%
ABVX	Abivax S.A. Healthcare	Reduced	130,000	-15,000	$14,475,500	−26.0%	5.30%
EWTX	Edgewise Therapeutics, Inc. Healthcare	Held	350,000	0	$11,025,000	+26.9%	4.04%
ZNTL	Zentalis Pharmaceuticals, Inc. Healthcare	NEW	4,031,000	NEW	$9,432,540	NEW	3.46%
NKTR	Nektar Therapeutics Healthcare	NEW	125,000	NEW	$8,993,750	NEW	3.30%
ANL	Adlai Nortye Ltd. Healthcare	NEW	1,265,231	NEW	$8,755,398	NEW	3.21%
RLAY	Relay Therapeutics, Inc. Healthcare	NEW	822,500	NEW	$8,183,875	NEW	3.00%
MAZE	Maze Therapeutics, Inc. Healthcare	Reduced	257,500	-232,500	$7,686,375	−62.1%	2.82%
IDYA	IDEAYA Biosciences, Inc. Healthcare	NEW	224,300	NEW	$7,473,676	NEW	2.74%
SCYX	Scynexis Inc Healthcare	NEW	7,608,695	NEW	$6,977,173	NEW	2.56%
CCCC	C4 Therapeutics, Inc. Healthcare	NEW	2,250,000	NEW	$5,917,500	NEW	2.17%
IKT	Inhibikase Therapeutics, Inc. Healthcare	Reduced	3,500,000	-725,000	$5,880,000	−32.1%	2.15%
PALI	Palisade Bio, Inc. Healthcare	Reduced	3,000,000	-1,500,000	$5,250,000	−50.4%	1.92%
EPRX	Eupraxia Pharmaceuticals Inc. Healthcare	Added	680,000	+180,000	$4,923,200	+30.4%	1.80%
GHRS	GH Research PLC Healthcare	Added	325,000	+10,000	$4,569,500	+14.2%	1.67%
KPTI	Karyopharm Therapeutics Inc. Healthcare	NEW	750,000	NEW	$4,177,500	NEW	1.53%
PMN	ProMIS Neurosciences Inc. Healthcare	NEW	324,977	NEW	$4,127,207	NEW	1.51%
LPCN	Lipocine Inc. Healthcare	Reduced	450,000	-80,000	$3,595,500	−15.5%	1.32%
IVA	Inventiva S.A. Healthcare	Added	535,000	+235,000	$2,969,250	+112.8%	1.09%
ALXO	Alx Oncology Holdings Inc Healthcare	NEW	1,460,000	NEW	$2,927,300	NEW	1.07%
CNTX	Context Therapeutics Inc. Healthcare	NEW	1,100,000	NEW	$2,882,000	NEW	1.06%
NXTC	NextCure, Inc. Healthcare	Added	265,000	+28,034	$2,830,200	−15.8%	1.04%
AVBP	ArriVent BioPharma, Inc. Healthcare	Reduced	110,000	-228,000	$2,537,700	−62.7%	0.93%
SLGL	Sol-Gel Technologies Ltd. Healthcare	NEW	31,000	NEW	$2,455,820	NEW	0.90%
KTTA	Pasithea Therapeutics Corp. Healthcare	Held	2,100,000	0	$1,558,200	−42.5%	0.57%
TRAW	Traws Pharma, Inc. Healthcare	Reduced	511,714	-201,826	$936,436	+16.1%	0.34%
TXMD	TherapeuticsMD, Inc. Healthcare	NEW	420,421	NEW	$849,250	NEW	0.31%
SPRB	Spruce Biosciences, Inc. Healthcare	Reduced	12,200	-127,800	$797,270	−93.5%	0.29%
HOWL	Werewolf Therapeutics, Inc. Healthcare	NEW	563,535	NEW	$469,424	NEW	0.17%
NEUP	Neuphoria Therapeutics Inc. Healthcare	NEW	76,728	NEW	$312,282	NEW	0.11%